HMG-CoAR expression in male breast cancer: relationship with hormone receptors, Hippo transducers and survival outcomes
Male breast cancer (MBC) is a rare hormone-driven disease often associated with obesity. HMG-CoAR is the central enzyme of the mevalonate pathway, a molecular route deputed to produce cholesterol and steroid-based hormones. HMG-CoAR regulates the oncogenic Hippo transducers TAZ/YAP whose expression...
Main Authors: | Di Benedetto, Anna, Mottolese, Marcella, Sperati, Francesca, Ercolani, Cristiana, Di Lauro, Luigi, Pizzuti, Laura, Vici, Patrizia, Terrenato, Irene, Shaaban, Abeer M., Sundara-Rajan, Sreekumar, Humphries, Matthew P., Barba, Maddalena, Speirs, Valerie, De Maria, Ruggero, Maugeri-Saccà, Marcello |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054365/ |
Similar Items
-
The Hippo transducers TAZ/YAP and their target CTGF in male breast cancer
by: Benedetto, Anna Di, et al.
Published: (2016) -
Topographic expression of the Hippo transducers TAZ and YAP in triple-negative breast cancer treated with neoadjuvant chemotherapy
by: Vici, Patrizia, et al.
Published: (2016) -
The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy
by: Vici, Patrizia, et al.
Published: (2014) -
p53 status as effect modifier of the association between pre-treatment fasting glucose and breast cancer outcomes in non diabetic, HER2 positive patients treated with trastuzumab
by: Vici, Patrizia, et al.
Published: (2014) -
Efficacy of chemotherapy in metastatic male breast cancer patients: a retrospective study
by: Di Lauro, Luigi, et al.
Published: (2015)